Comparative cardiovascular and renal effectiveness of empagliflozin and dapagliflozin: scandinavian cohort study
Engström A, Söderling J, Hviid A, et al.
Eur Heart J Cardiovasc Pharmacother. Pub. online 25 Jun 2024.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Engström A, Söderling J, Hviid A, et al.
Eur Heart J Cardiovasc Pharmacother. Pub. online 25 Jun 2024.
Leggi
Saravanan P, Deepa M, Ahmed Z, et al.
Lancet Diabetes Endocrinol. Pub. online 24 Jun 2024.
Leggi
Verma S, Butler J, Borlaug BA, et al.
J Am Coll Cardiol. Pub. online 19 Jun 2024.
Leggi
Gaglia JL, Daley HL, Bryant NK, et al.
NEJM Evid. Pub. online 25 Jun 2024.
Leggi
Hivert MF, Backman H, Benhalima K, et al.
Lancet. Pub. online 18 Jun 2024.
Leggi
Van Rampelbergh J, Achenbach P, Leslie RD, et al.
BMC Med. Pub. online 21 Jun 2024.
Leggi
O’Connor EA, Evans CV, Henninger M, et al.
JAMA. Pub. online 18 Jun 2024.
Leggi
Rahimlou M, Ahmadi AR, Cheraghian B, et al.
BMC Endocr Disord. Pub. online 19 Jun 2024.
Leggi
Liu S, Yu J, Lu W, et al.
Nutr Metab Cardiovasc Dis. Pub. online 24 Jun 2024.
Leggi
Malhotra A, Grunstein RR, Fietze I, et al.
N Engl J Med. Pub. online 21 Jun 2024.
Leggi